Proteomics techniques in protein biomarker discovery.

Area of Science:

• Biochemistry
• Proteomics
• Cancer Diagnostics

Background:

• Protein biomarkers have been vital in cancer diagnosis and care for over 50 years.
• Advancements in proteomics have yielded thousands of potential protein biomarkers for various diseases.
• Proteomics diagnosis involves sample pretreatment, purification, and analysis using advanced techniques.

Purpose of the Study:

• To investigate recent improvements in protein biomarker discovery, verification, and validation.
• To discuss the advantages and disadvantages of conventional proteomics techniques.
• To highlight the role of mass spectrometry and other methods in biomarker development.

Main Methods:

• Utilized mass spectrometry (MS) for protein identification and quantification.
• Explored multiple reaction monitoring (MRM), parallel reaction monitoring (PRM), and selected reaction monitoring (SRM) for biomarker verification.
• Considered enzyme-linked immunosorbent assay (ELISA) for biomarker validation.

Main Results:

• Mass spectrometry is a critical technique for identifying and quantifying candidate biomarkers.
• Verification and validation are essential post-discovery to minimize false positives, especially with large sample sets.
• MRM, PRM, SRM with stable isotope-labeled internal standards, and ELISA are key methods for verification and validation.

Conclusions:

• Recent improvements enhance the reliability of protein biomarker discovery and validation.
• Careful selection of verification and validation techniques is crucial for accurate cancer diagnostics.
• The study provides insights into the evolving landscape of proteomics in clinical applications.